AI illustration · not actual product photoDetails from the source.
Source-listed Melatonin (SKU MT10): 10mg*10vials. PriceList(1).pdf lists 63 per 10 vials but does not specify currency; the website displays $63 per 10 vials in USD per owner instruction. The source row does not establish the supplier-specific item's identity, lot quality, or approval.
- Catalogue code
- MT10
- Source specification
- 10mg*10vials
- Source document
- PriceList(1).pdf, page 4
- Photograph
- AI-generated illustration only — not an actual product photo or verified molecular depiction; owner-approved product photo still pending.
Product information is presented from supplied source materials. Inclusion on this website does not state that a product is an approved medicine or authorize human use. This is educational content, not medical advice.
Compound-level research and safety context.
Evidence below concerns the research family associated with this listing. For blends, findings about individual components do not establish evidence for the combination. This does not verify the supplier-specific vial or lot. Reviewed 2026-10-30.
What it is
The exact catalogue label is “Melatonin” (SKU MT10), specification “*10vials,” price 63 per 10 vials; currency is not stated in the PDF. Melatonin is an endogenous indoleamine hormone, not a peptide. The catalogue does not establish the identity, source, formulation, or quality of this specific vial.
Biological mechanism
Melatonin production rises in darkness and conveys a night-time signal to the central circadian clock in the suprachiasmatic nucleus (SCN). Human research describes effects on SCN signaling that can influence circadian timing and sleep propensity. This biological mechanism does not establish a clinical effect from the unidentified catalogue vial. [1] [2]
Research focus
Human research has studied melatonin products in circadian timing and sleep, including jet lag, delayed sleep–wake phase disorder, selected pediatric sleep problems, and perioperative anxiety. Evidence differs by condition; studies of shift-work sleep are limited or inconclusive, and authoritative summaries report insufficient strong evidence to recommend melatonin supplements for chronic insomnia. [1] [2]
Potential applications in the evidence
As investigated in human studies, melatonin has been evaluated for selected sleep-timing and circadian-related outcomes, including jet lag and delayed sleep–wake phase disorder, and for anxiety around surgery. These are areas of research, not claims that this vial treats or prevents any condition. Evidence for chronic insomnia and shift-work sleep is insufficient or inconclusive. [1]
Human evidence
Some controlled human studies and reviews report improvements in selected sleep-timing outcomes for particular formulations and populations. NCCIH summarizes a four-week trial in delayed sleep–wake phase disorder reporting earlier sleep onset and some improved daytime functioning. Such findings do not establish efficacy, equivalence, or quality for this unidentified vial, nor broad disease-prevention, anti-aging, or general therapeutic effects. [1] [2]
Known and potential effects
Short-term human studies have reported headache, dizziness, nausea, and sleepiness. Long-term effects remain unclear. Older adults may experience longer-lasting activity and daytime drowsiness. [1]
Safety and contraindications
Long-term safety and use during pregnancy or breastfeeding are insufficiently studied. NCCIH identifies potential allergy risk and notes that people with epilepsy or taking blood thinners need medical supervision when melatonin is considered; possible hormonal-development effects in children remain uncertain. CDC poison-center surveillance documented increasing pediatric ingestions, including hospitalizations and rare severe outcomes; these reports concern ingestion events and do not quantify risk from routine use. No safety guarantee can be made for this unverified vial. [1] [3]
U.S. FDA / regulatory status
NCCIH describes melatonin generally as a dietary supplement in the United States. FDA states dietary supplements are not approved before marketing for safety and effectiveness; this does not establish that this catalogue vial qualifies as a dietary supplement or is lawfully marketed. The PDF supplies no manufacturer, product label, jurisdiction, FDA application number, NDC, or approved branded formulation. No FDA approval for this exact item is evidenced, and approval or evidence for an active ingredient or another formulation would not transfer to it. The sources reviewed do not establish a specific FDA-approved melatonin drug product relevant to this vial. Do not label it FDA-approved, compounded, or research-only without product-specific documentation. [1] [4]
Evidence limitations
Evidence is formulation-, population-, outcome-, and study-duration-specific. Some studies are small or brief, or evidence is rated low quality or inconclusive. The reviewed clinical findings concern melatonin products as studied, not SKU MT10. No product label, certificate of analysis, lot testing, identity/purity data, or manufacturing records were supplied. The catalogue's price currency is also unspecified.
Supporting sources
- Melatonin: What You Need To Know National Center for Complementary and Integrative Health (NCCIH), NIH · U.S. government evidence and safety summary. Supports: Definition and physiology; human evidence by research area; reported adverse effects, interactions, special-population cautions, and evidence gaps.
- New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation British Journal of Pharmacology, available through PubMed Central · Peer-reviewed review. Supports: Circadian mechanism, SCN signaling, and synthesis of human sleep/circadian research.
- Pediatric Melatonin Ingestions — United States, 2012–2021 Centers for Disease Control and Prevention (CDC), Morbidity and Mortality Weekly Report · U.S. public-health surveillance study. Supports: Pediatric ingestion surveillance and associated hospitalization and serious-outcome context; study limitations.
- Questions and Answers on Dietary Supplements U.S. Food and Drug Administration (FDA) · Regulatory Q&A. Supports: U.S. dietary-supplement category and FDA premarket approval framework; manufacturer responsibility and labeling requirements.